# \[e-drug\] Further dirty tricks in Australia

**URL:** <https://talk.edrugplus.org/t/e-drug-further-dirty-tricks-in-australia/11975>\
**Category:** e-drug\
**Created:** [July 25, 2001, 9:50am UTC](https://talk.edrugplus.org/t/e-drug-further-dirty-tricks-in-australia/11975 "2001-07-25T09:50:59Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![mddah](https://avatars.discourse-cdn.com/v4/letter/m/f0a364/32.png) [@mddah](https://talk.edrugplus.org/u/mddah)\
**Post date:** [July 25, 2001, 9:50am UTC](https://talk.edrugplus.org/t/e-drug-further-dirty-tricks-in-australia/11975/1 "2001-07-25T09:50:59Z")

</div>

E-drug: Further dirty tricks in Australia  
-------------------------------------------------------------------------

Recent events have moved me to put on record some of the further  
experiences of former members of the Australian Pharmaceutical  
Benefits Advisory Committee and their supporters. As some readers  
of this site will be aware, most PBAC members (10/12) were  
sacked or resigned in December 2000 after a serious disagreement  
with the Australian government, which viewed the committee as  
having an unduly adversarial relationship with the pharmaceutical  
industry. An investigative television program (ABC Four Corners)  
established that the industry had lobbied to have particular  
members removed from the committee and to place an industry  
representative on the committee.

Most of us who were involved thought that the dissolution of the  
committee would be the end of the matter and we could get on  
with our lives. Not so...

Three people have been targeted for special continued attention - 2  
former members Martyn Goddard and myself, and a supporter, Dr  
Ken Harvey from La Trobe University (Melbourne).

Ken Harvey was unexpectedly accused by his institution of serious  
misconduct for posting on a university Web site news articles and  
published cartoons relating to the PBAC debacle. The material, an  
extremely useful summary of the history and background to the  
events, had links to published material that featured alleged  
relations between the federal health minister and the pharmaceutical  
industry. The material had been available for some time and the  
timing of the University's attack on Dr Harvey was a surprise to all.  
As you know, the latest news is that the university has not  
proceeded with official action and has settled its differences with  
Dr Harvey (who appears unable to comment) - I feel sure that the  
many international expressions of support must have helped.

Martyn Goddard is a very effective consumer advocate, and was a  
consumer representative on the PBAC; he is well known in Australia  
as a journalist and AIDS activist. He tried harder than anyone to  
hold together the remnants of the old committee, but after an  
industry representative was placed on the PBAC he resigned and  
became an outspoken critic of the present government and the  
industry. He has been dropped from all his committee advisory and  
consulting roles - with no warning or justification.

In my case, federal health department officials were ordered to  
retrieve any documents relating to me. Subsequently, confidential  
documents were released to a PR company and then to news  
outlets with an accompanying written commentary that accused me  
of taking money from a pharmaceutical company and biasing PBAC  
decisions in favour of that company's products (and against  
another's). Fortunately, some very good journalists chased down  
the truth (the story was a complete fabrication and was easily  
disproved).

There has been a systematic campaign in Australia to discredit  
former members of the Australian PBAC and their supporters.

It seems that anyone who makes a stand on issues of equity and  
fair prices for pharmaceutical products should expect to encounter  
such tactics.

David Henry  
Professor of Clinical Pharmacology,  
Head of School of Population Health Sciences,  
Faculty of Medicine and Health Sciences,  
The University of Newcastle, NSW

Phone + 61 249 211856  
Fax +61 249 602088

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Information and archive [http://satellife.healthnet.org/programs/edrug.html](http://satellife.healthnet.org/programs/edrug.html)  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
